Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial-Reference-Cited by-同舟云学术

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Published:2024-04 Issue:10434 Volume:403 Page:1341-1350
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Lorusso Domenica,Xiang Yang,Hasegawa Kosei,Scambia Giovanni,Leiva Manuel,Ramos-Elias Pier,Acevedo Alejandro,Sukhin Vladyslav,Cloven Noelle,Pereira de Santana Gomes Andrea J,Contreras Mejía Fernando,Reiss Ari,Ayhan Ali,Lee Jung-Yun,Saevets Valeriya,Zagouri Flora,Gilbert Lucy,Sehouli Jalid,Tharavichitkul Ekkasit,Lindemann Kristina,Lazzari Roberta,Chang Chih-Long,Lampé Rudolf,Zhu Hong,Oaknin Ana,Christiaens Melissa,Polterauer Stephan,Usami Tomoka,Li Kan,Yamada Karin,Toker Sarper,Keefe Stephen M,Pignata Sandro,Duska Linda R

Funder

Meso Scale Diagnostics

Publisher

Elsevier BV

Reference27 articles.

1. Improved treatment for cervical cancer—concurrent chemotherapy and radiotherapy;Thomas;N Engl J Med,1999

2. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials;J Clin Oncol,2008

3. Cancer of the cervix uteri;Bhatla;Int J Gynaecol Obstet,2018

4. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01;Eifel;J Clin Oncol,2004

5. Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial;Shrivastava;JAMA Oncol,2018

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of immune, inflammatory and nutritional indices on outcome in patients with locally advanced cervical cancer treated with definitive (chemo)radiotherapy;Gynecologic Oncology;2024-11

2. Regarding “Immunotherapy in locally advanced cervix cancer: A critical appraisal of the FDA indication based on ENGOT-CX11/GOG-3047/KEYNOTE-A18”;Gynecologic Oncology;2024-10

3. The prognostic value of Th17/Treg cell in cervical cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-09-11

4. Pembrolizumab plus Radiochemotherapie bei lokal fortgeschrittenem Zervixkarzinom – die prospektive, randomisierte KEYNOTE-A18-Phase-3-Studie;Strahlentherapie und Onkologie;2024-09-04

5. Ocular side effects of anticancer agents used in the treatment of gynecologic cancers;Gynecologic Oncology;2024-09